The dystrophinopathies: an alternative to the structural hypothesis
- PMID: 9702783
- DOI: 10.1006/nbdi.1998.0188
The dystrophinopathies: an alternative to the structural hypothesis
Abstract
Abnormal expression of the cytoskeletal protein dystrophin has deleterious consequences for skeletal muscle, cardiac muscle, and the central nervous system. A complete failure to express the protein produces Duchenne muscular dystrophy (DMD), in which there is extensive and progressive skeletal muscle necrosis, the development of a life-threatening dilated cardiomyopathy, and mild mental retardation. Dystrophin binds the F-actin cytoskeleton and is normally expressed in a complex of transmembrane proteins (the "dystrophin protein complex") that interact with external components of the basal lamina. One pathogenic model for DMD (the "structural hypothesis") suggests that this complex forms a structural bridge between the external basal lamina and the internal cytoskeleton and that the absence of dystrophin produces a defect in membrane structural support that renders skeletal muscle susceptible to plasmalemmal ruptures (or "tears") during the course of contractile activity. This review attempts to critically evaluate the structural hypothesis for DMD and presents an opposing model (the "channel aggregation model") that highlights the role of dystrophin in organizing the membrane cytoskeleton and the role of the cytoskeleton in aggregating ion channels and neurotransmitter receptors. Since ion channel aggregation is a process that is common across organ systems, the idea that channel function can be altered when aggregated ion channels interact with a dystrophic cytoskeleton has immediate implications for the expression of the dystrophinopathies in skeletal muscle, cardiac muscle, and the central nervous system.
Similar articles
-
Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.Nat Genet. 1999 Nov;23(3):338-42. doi: 10.1038/15519. Nat Genet. 1999. PMID: 10610181
-
Function and genetics of dystrophin and dystrophin-related proteins in muscle.Physiol Rev. 2002 Apr;82(2):291-329. doi: 10.1152/physrev.00028.2001. Physiol Rev. 2002. PMID: 11917091 Review.
-
Muscular dystrophies related to the cytoskeleton/nuclear envelope.Novartis Found Symp. 2005;264:98-111; discussion 112-7, 227-30. Novartis Found Symp. 2005. PMID: 15773750 Review.
-
Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.Microsc Res Tech. 2000 Apr 1;49(1):90-100. doi: 10.1002/(SICI)1097-0029(20000401)49:1<90::AID-JEMT10>3.0.CO;2-L. Microsc Res Tech. 2000. PMID: 10757882 Review.
-
Redefinition of dystrophin isoform distribution in mouse tissue by RT-PCR implies role in nonmuscle manifestations of duchenne muscular dystrophy.Mol Genet Metab. 1998 Dec;65(4):272-81. doi: 10.1006/mgme.1998.2763. Mol Genet Metab. 1998. PMID: 9889014
Cited by
-
Dystrophin is required for appropriate retrograde control of neurotransmitter release at the Drosophila neuromuscular junction.J Neurosci. 2006 Jan 4;26(1):333-44. doi: 10.1523/JNEUROSCI.4069-05.2006. J Neurosci. 2006. PMID: 16399704 Free PMC article.
-
Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance.J Cardiovasc Magn Reson. 2023 Feb 16;25(1):14. doi: 10.1186/s12968-023-00922-3. J Cardiovasc Magn Reson. 2023. PMID: 36793101 Free PMC article.
-
Age-associated sleep spindle characteristics in Duchenne muscular dystrophy.Sleep Adv. 2024 Mar 14;5(1):zpae015. doi: 10.1093/sleepadvances/zpae015. eCollection 2024. Sleep Adv. 2024. PMID: 38525359 Free PMC article.
-
Myocardial cell damage in Duchenne muscular dystrophy.Pediatr Cardiol. 2003 Sep-Oct;24(5):503-6. doi: 10.1007/s00246-002-0408-9. Pediatr Cardiol. 2003. PMID: 14627325
-
Left Ventricular Tonic Contraction as a Novel Biomarker of Cardiomyopathy in Duchenne Muscular Dystrophy.Pediatr Cardiol. 2016 Apr;37(4):678-85. doi: 10.1007/s00246-015-1331-1. Epub 2015 Dec 29. Pediatr Cardiol. 2016. PMID: 26714815
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical